Scientists investigate whether amylin triggers diabetic nerve pain

NCT ID NCT03481283

First seen Feb 02, 2026 · Last updated May 15, 2026 · Updated 9 times

Summary

This study looks at whether a hormone called amylin, which is higher in people with type 2 diabetes, is linked to nerve damage (peripheral neuropathy). Researchers will collect blood and small skin samples from 40 participants to measure amylin levels and compare them to nerve function and pain sensitivity. The goal is to understand if amylin plays a role in causing neuropathy, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UK Robert Straus Behavioral Science Laboratory

    ACTIVE_NOT_RECRUITING

    Lexington, Kentucky, 40508, United States

  • University of Kentucky - Kentucky Neuroscience Institute

    RECRUITING

    Lexington, Kentucky, 40536, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.